Overseas expansion key for healthcare sector in 2019 and beyond: analysts
Having overseas entities will help firms manage in an increasingly competitive medical tourism market
Add BT as a preferred source
Singapore
WITH some exceptions, the healthcare sector was not spared the trade tensions and uncertainty that dogged equity markets throughout 2018.
Going forward, cost pressures and macroeconomic headwinds are expected to moderate prospects in 2019, but the long-term view is rosier, especially for companies with overseas operations. Analysts project a positive outlook beyond 2019 when recent regional expansions for players such as IHH Healthcare Bhd and Singapore Medical Group (SMG) will start to yield results, if handled successfully.
TRENDING NOW
Singapore is showing why cooling is the next investment asset
Nearly half of Apac’s wealthy expect market crash or correction, plan to rotate to cash: study
Shanda co-founder sells Tanglin Hill bungalow for S$76 million
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
